NEW YORK (GenomeWeb) – A subset of breast cancers contain mutational signatures consistent with DNA mismatch repair (MMR) deficiency, new research reveals, suggesting that some individuals with the disease may benefit from immune checkpoint blockade immunotherapies similar to those being used in other types of cancer with MMR deficits.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.